Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506.
Hossein-Nia
M
M
Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom.
Devlin
J J
JJ
Fagbohun
M
M
Tredger
J M
JM
Williams
R
R
Johnston
A
A
Holt
D W
DW
D000118:Acetylglucosaminidase / Q000652:urine; D000284:Administration, Oral; D000328:Adult; D015415:Biomarkers / Q000652:urine; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D015415:Biomarkers; D016572:Cyclosporine; D000118:Acetylglucosaminidase; D016559:Tacrolimus